Skip to main content

Table 2 Anthropometrical evaluation and serum C-reactive protein levels in human immunodeficiency virus (HIV)-infected and HIV-uninfected children being treated for tuberculosis on enrolment after 1 month and 4 months of treatment.

From: Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis

  Human immunodeficiency virus-infected
N= 21 (SD)
Human immunodeficiency virus-
uninfected
N= 33
(SD)
Pvalue Human immunodeficiency virus-infected
N= 21
(SD)
Human immunodeficiency virus-uninfected
N= 33
(SD)
Pvalue
  On enrolment    After 4 months of
treatment
  
Weight (kg) 12.26
(5.18)
13.97
(6.94)
0.30 13.06
(5.33)
15.04
(8.01)
0.29
Length/height (cm) 86.80
(16.22)
91.53
(20.85)
0.36 89.26
(16.39)
93.67
(20.37)
0.40
Body mass index 15.59
(1.62)
15.71
(1.91)
0.80 15.74
(1.53)
16.05
(1.71)
0.51
Mid-upper arm circumference (cm) 14.28
(2.16)
15.07
(2.39)
0.21 14.44
(2.22)
15.46
(2.63)
0.16
Serum C-reactive protein
(mg/litre)
39.97
(54.55)
13.42
(17.96)
0.06 22.47
(22.28)
4.15
(4.96)
0.002
  1. SD, standard deviation.